A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D₂ receptor antagonist in the treatment of acute exacerbation of schizophrenia (Q48251371)
Jump to navigation
Jump to search
scientific article published on 31 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D₂ receptor antagonist in the treatment of acute exacerbation of schizophrenia |
scientific article published on 31 March 2012 |
Statements
1 reference
A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D₂ receptor antagonist in the treatment of acute exacerbation of schizophrenia (English)
1 reference
Mark E Schmidt
1 reference
Justine M Kent
1 reference
Ella Daly
1 reference
Luc Janssens
1 reference
Nancy Van Osselaer
1 reference
Gitta Hüsken
1 reference
Ion-George Anghelescu
1 reference
Luc Van Nueten
1 reference
31 March 2012
1 reference
22
1 reference
10
1 reference
721-733
1 reference